Associated Papers
Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing.
Zheng Q et al.
Cancer Cell International, 2025
40075389 (PubMed )
Supplement: 12935_2025_3699_MOESM2_ESM.xlsx › Sheet1
Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours.
Gheorghe AM et al.
International Journal of Molecular Sciences, 2024
A family case report of parathyroid carcinoma associated with CDC73 mutation in hyperparathyroidism-jaw tumor syndrome.
Gu Y et al.
Frontiers in Endocrinology, 2024
Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY et al.
Experimental & Molecular Medicine, 2023
Mutational landscape and genetic signatures of cell-free DNA in tumour-induced osteomalacia.
Wu N et al.
Journal of Cellular and Molecular Medicine, 2020
32277576 (PubMed )
Supplement: JCMM-24-4931-s011.xlsx › Sheet1
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K et al.
The Journal of Clinical Endocrinology and Metabolism, 2017
Targeted Next-Generation Sequencing of MEN 1, RET, CDC 73, and CDKNIB Genes in Familial Primary Hyperparathyroidism: A Study from Northern India.
Qadir A et al.
Indian Journal of Endocrinology and Metabolism, 0
Select a paper to view details